Publications by authors named "Adrienne E Kaufman"
Background: Plasma-based circulating cell-free tumor DNA (ctDNA) genomic profiling by next-generation sequencing (NGS)is an emerging diagnostic tool for pancreatic cancer (PC). The impact of detected genomic alterations and variant allele fraction (VAF) in tumor response to systemic treatments and outcomes is under investigation.
Methods: Patients with advanced PC who had ctDNA profiled at time of initial diagnosis were retrospectively evaluated.